Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06478693
Title A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCC
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Myeloid Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS


No variant requirements are available.